Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,761–9,780 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass III

Tramadol Hydrochloride 50 mg tablets, 120-count, Rx Only; Distributed by Quality Care Products, Temperance, MI 48182 Mfr. CSPC Ouyl Pharm Co., Ltd. Shijazhuang, Hebei, China; NDC 55700-0412-01

by Lake Erie Medical & Surgical Supply Inc

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Recall initiated
March 19, 2018
Reported by FDA
April 18, 2018
Distribution
FL, VA

View recall →

Drug Recall Terminated Historical recordClass II

Zhong Hua Jiu (menthol 1%) Patch, Distributed by United Pacific Company, UPC 6 924938 100226, NDC 53614-001-02

by United Pacific Co Ltd

Reason
CGMP Deviations: the product was produced with substandard GMP manufacturing processes.
Recall initiated
March 29, 2018
Reported by FDA
April 18, 2018
Distribution
Nationwide within US

View recall →

Drug Recall Terminated Historical recordClass II

Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL

by Elroselabs Inc.

Reason
cGMP Deviations
Recall initiated
March 28, 2018
Reported by FDA
April 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.

by Elroselabs Inc.

Reason
cGMP Deviations
Recall initiated
March 28, 2018
Reported by FDA
April 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06

by Elroselabs Inc.

Reason
cGMP Deviations
Recall initiated
March 28, 2018
Reported by FDA
April 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097-878-07) bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788

by InvaGen Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications; during stability testing
Recall initiated
March 15, 2018
Reported by FDA
April 11, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03

by InvaGen Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications; during stability testing
Recall initiated
March 15, 2018
Reported by FDA
April 11, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

by Mayne Pharma Inc

Reason
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Recall initiated
March 21, 2018
Reported by FDA
April 11, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass I

Red Zone Xtreme 3000 Capsules, Dietary Supplement Product, 1 count blister pack, UPC 8 91656 00200 9, Exp Date 12/31/2021

by Jimmy Weber

Reason
Marketed without an Approved NDA/ANDA; FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.
Recall initiated
March 8, 2018
Reported by FDA
April 4, 2018
Distribution
Product was distributed online via eBay.

View recall →

Drug Recall Terminated Historical recordClass II

Vancomycin 1.25g added to 250 mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101, Columbia, MO 65202, NDC 71170-254-25.

by Apollo Care

Reason
Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.
Recall initiated
March 7, 2018
Reported by FDA
April 4, 2018
Distribution
Medical Facility in MO

View recall →

Drug Recall Terminated Historical recordClass II

Vancomycin 1g added to 250mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101, Columbia, MO 65202, NDC 71170-254-25.

by Apollo Care

Reason
Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.
Recall initiated
March 7, 2018
Reported by FDA
April 4, 2018
Distribution
Medical Facility in MO

View recall →

Drug Recall Terminated Historical recordClass III

24-HOUR Oral Care q4 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA 30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97014.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Recall initiated
March 29, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

24-HOUR Oral Care q2 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA 30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97012.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Recall initiated
March 29, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-720-15) packaged in 100-count (10 x 10) cups per case pack (NDC 50383-720-18 or 50383-720-19), Rx Only, Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Recall initiated
March 29, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Fosphenytoin Sodium Injection, USP 500 mg PE*/10 mL, Made in India. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807, NDC 70121-1390-1

by Amneal Pharmaceuticals

Reason
Presence of particulate matter
Recall initiated
December 15, 2017
Reported by FDA
April 4, 2018
Distribution
U.S.A Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

E-Z-Paste Barium Sulfate Esophageal Cream (60% w/w), 454 g tube, Rx only, Manufactured by E-Z-EM Canada Inc. for E-Z-EM Inc. a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 0883, NDC 32909-770-01

by Bracco Diagnostics Inc.

Reason
Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.
Recall initiated
March 8, 2018
Reported by FDA
April 4, 2018
Distribution
Product was distributed throughout the United States, Hong Kong and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

by Paddock Laboratories, LLC.

Reason
Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.
Recall initiated
February 26, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide within the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-302-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.
Recall initiated
March 19, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide in the United States.

View recall →

Drug Recall Terminated Historical recordClass III

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

by Renaissance Lakewood, LLC

Reason
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Recall initiated
March 2, 2018
Reported by FDA
April 4, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

by Teva Pharmaceuticals USA

Reason
Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.
Recall initiated
March 19, 2018
Reported by FDA
March 28, 2018
Distribution
Distributed within the United States and Puerto Rico.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.